Welcome to LookChem.com Sign In|Join Free

CAS

  • or

83-74-9

Post Buying Request

83-74-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

83-74-9 Usage

Description

This indole alkaloid occurs in the root of Tabernanthe iboga Baill. It was first examined in detail by Raymond-Hamet who assigned to it the empirical formula C19H24(26)ON2, now altered to that given above. The base forms colourless crystals from EtOH and is laevorotatory with [Q1D - 53° (EtOH). It is insoluble in Et20, slightly so in Me2CO or CHC1 3 but dissolves freely in MeOH, EtOH or H20. The alkaloid yields a hydrochloride, m.p. 299°C (dec.); lQlhs - 67° (MeOH) or - 37.3° (H20). It contains one methoxyl group and gives the typical indole reactions. On distillation with Zn dust or soda-lime it furnishes products which are indole derivatives with the ~-position free. In a manner similar to that of cocaine, the alkaloid potentiates the pressor action of adrenaline and abolishes the sino-carotid reflexes. Unlike cocaine, however, it also augments the action of tyramine and that of dl-ephedrine to a slight extent. Vincent and Sero have reported that it inhibits the action of serum cholinesterase.

Purification Methods

Crystallise it from EtOH or aqueous EtOH and sublime it at 150o/0.01mm. It is soluble in organic solvents but insoluble in H2O. The hydrochloride, m 299-300o(dec), is soluble in H2O and alcohols. [Büchi et al. J Am Chem Soc 88 3099 1866, Rosenmund Chem Ber 108 1871 1975, Beilstein 23 III/IV 2742.]

References

Raymond-Hamet., Bull. Soc. Chirn. Fr., 9,620 (1942) Delourme-Houde., Chern. Abstr., 41, 1390 (1947) Bartlett, Dickel, Taylor.,J. Arner. Chern. Soc., 80, 126 (1958) Arai, Coppola, Jeffery., Acta Cryst., 13, 553 (1960) Shamma, Soyster., Experientia, 20,36 (1964) Synthesis: Buchi et ai., f. Arner. Chern. Soc., 88,3099 (1966) Pharmacology: Raymond-Hamet, Rothlin., C.R. Soc. Bioi., 127,592 (1938) Raymond-Hamet, Rothlin., Arch. inst. Pharrnacodyn., 63, 27 (1939) Raymond-Hamet., Cornpt. rend., 201,285 (1940) Raymond-Hamet., C.R. Soc. Bioi., 135, 176 (1941) Raymond-Hamet, Perrot., Bull. Acad. Med., 24,423 (1941) Vincent, Sero., C.R. Soc. Bioi., 136,612 (1942)

Check Digit Verification of cas no

The CAS Registry Mumber 83-74-9 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 8 and 3 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 83-74:
(4*8)+(3*3)+(2*7)+(1*4)=59
59 % 10 = 9
So 83-74-9 is a valid CAS Registry Number.
InChI:InChI=1/C20H26N2O/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3/t12-,13+,17+,20+/m1/s1

83-74-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name IBOGAINE

1.2 Other means of identification

Product number -
Other names 12-methoxy-ibogamin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:83-74-9 SDS

83-74-9Synthetic route

voacangine
510-22-5

voacangine

ibogaine
83-74-9

ibogaine

Conditions
ConditionsYield
Stage #1: voacangine With potassium hydroxide In ethanol Reflux;
Stage #2: With hydrogenchloride In water at 0℃; for 0.0833333h; pH=1; Reflux;
86%
With potassium hydroxide Erwaermen der Reaktionsloesung mit methanol. HCl;
12-methoxy-20,21-didehydro-ibogamine
113950-91-7

12-methoxy-20,21-didehydro-ibogamine

ibogaine
83-74-9

ibogaine

Conditions
ConditionsYield
Hydrogenation;
12-methoxy-ibogamin-19-one
2637-13-0

12-methoxy-ibogamin-19-one

ibogaine
83-74-9

ibogaine

Conditions
ConditionsYield
With tetrahydrofuran; lithium aluminium tetrahydride
(17S)-12-methoxy-9,17-dihydro-8,17-cyclo-8,9-seco-ibogamin-9-one

(17S)-12-methoxy-9,17-dihydro-8,17-cyclo-8,9-seco-ibogamin-9-one

ibogaine
83-74-9

ibogaine

Conditions
ConditionsYield
With lithium aluminium tetrahydride; diethyl ether
ibogaine
83-74-9

ibogaine

12-hydroxyibogamine
481-88-9

12-hydroxyibogamine

Conditions
ConditionsYield
With iodine; aluminium In acetonitrile for 3h; Reflux;76%
tetrahydrofuran
109-99-9

tetrahydrofuran

ibogaine
83-74-9

ibogaine

iodine
7553-56-2

iodine

NaHCO3

NaHCO3

12-methoxy-ibogamin-19-one
2637-13-0

12-methoxy-ibogamin-19-one

pyridine
110-86-1

pyridine

ibogaine
83-74-9

ibogaine

CrO3

CrO3

12-methoxy-16,17-didehydro-9,17-dihydro-ibogamin-9α-yl hydroperoxide
111066-15-0

12-methoxy-16,17-didehydro-9,17-dihydro-ibogamin-9α-yl hydroperoxide

pyridine
110-86-1

pyridine

ibogaine
83-74-9

ibogaine

CrO3

CrO3

A

12-methoxy-ibogamin-19-one
2637-13-0

12-methoxy-ibogamin-19-one

B

12-methoxy-ibogamine-8,19-dione
111411-40-6

12-methoxy-ibogamine-8,19-dione

chloroform
67-66-3

chloroform

ibogaine
83-74-9

ibogaine

air oxygen

air oxygen

A

iboluteine

iboluteine

B

ibochin

ibochin

Conditions
ConditionsYield
Irradiation;
ibogaine
83-74-9

ibogaine

benzyl chloroformate
501-53-1

benzyl chloroformate

N-CBZ-noribogaine

N-CBZ-noribogaine

Conditions
ConditionsYield
Stage #1: ibogaine; benzyl chloroformate With N-ethyl-N,N-diisopropylamine at 20℃; Inert atmosphere;
Stage #2: With boron tribromide Inert atmosphere;
ibogaine
83-74-9

ibogaine

ibogaine hydrochloride
5934-55-4

ibogaine hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In diethyl ether
ibogaine
83-74-9

ibogaine

12-hydroxyibogamine hydrochloride
110514-35-7

12-hydroxyibogamine hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aluminium; iodine / acetonitrile / 3 h / Reflux
2: hydrogenchloride / diethyl ether
View Scheme

83-74-9Relevant articles and documents

-

Renner et al.

, p. 1572,1577 (1959)

-

Biosynthesis of an Anti-Addiction Agent from the Iboga Plant

Farrow, Scott C.,Kamileen, Mohamed O.,Caputi, Lorenzo,Bussey, Kate,Mundy, Julia E. A.,McAtee, Rory C.,Stephenson, Corey R. J.,O'Connor, Sarah E.

, p. 12979 - 12983 (2019/08/26)

(-)-Ibogaine and (-)-voacangine are plant derived psychoactives that show promise as treatments for opioid addiction. However, these compounds are produced by hard to source plants, making these chemicals difficult for broad-scale use. Here we report the complete biosynthesis of (-)-voacangine, and de-esterified voacangine, which is converted to (-)-ibogaine by heating, enabling biocatalytic production of these compounds. Notably, (-)-ibogaine and (-)-voacangine are of the opposite enantiomeric configuration compared to the other major alkaloids found in this natural product class. Therefore, this discovery provides insight into enantioselective enzymatic formal Diels-Alder reactions.

NORIBOGAINE COMPOSITIONS

-

Page/Page column 15-16, (2012/02/05)

Disclosed are noribogaine compositions comprising a very high level of the 2(R), 4(S), 5(S), 6(S) and 18(R) enantiomer and not more than 0.5 wt% of ibogaine relative to the total amount of noribogaine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 83-74-9